Display options
Cite
Dutta P, Mahendran B, Reddy KS, et al. Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocr Connect. 2015;4(1):65-75doi: 10.1530/EC-14-0132.
Dutta, P., Mahendran, B., Reddy, K. S., Ahluwalia, J., Vaiphei, K., Kochhar, R. K., Gupta, P., Srinivasan, A., Prakash, M., Mukherjee, K. K., Shah, V. N., Parthan, G., & Bhansali, A. (2015). Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocrine connections, 4(1), 65-75. https://doi.org/10.1530/EC-14-0132
Dutta, Pinaki, et al. "Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience." Endocrine connections vol. 4,1 (2015): 65-75. doi: https://doi.org/10.1530/EC-14-0132
Dutta P, Mahendran B, Reddy KS, Ahluwalia J, Vaiphei K, Kochhar RK, Gupta P, Srinivasan A, Prakash M, Mukherjee KK, Shah VN, Parthan G, Bhansali A. Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocr Connect. 2015 Mar;4(1):65-75. doi: 10.1530/EC-14-0132. Epub 2015 Jan 19. PMID: 25600246; PMCID: PMC4321405.
Copy Download .nbib Format: NLM
Share it on

Endocr Connect. 2015 Mar;4(1):65-75. doi: 10.1530/EC-14-0132. Epub 2015 Jan 19.

Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience.

Endocrine connections

Pinaki Dutta, Bhuvanesh Mahendran, K S Reddy, Jasmina Ahluwalia, Kim Vaiphei, R K Kochhar, Prakamya Gupta, Anand Srinivasan, Mahesh Prakash, Kanchan Kumar Mukherjee, V N Shah, Girish Parthan, Anil Bhansali

Affiliations

  1. Department of Endocrinology4th Floor, F Block, Post Graduate Institute of Medical Education and Research, Nehru Hospital, Chandigarh 160012, IndiaInternal MedicineCardiologyHematologyHistopathologyGastroenterologyNeurosurgeryPharmacologyRadiodiagnosisPost Graduate Institute of Medical Education and Research, Chandigarh 160012, India [email protected].
  2. Department of Endocrinology4th Floor, F Block, Post Graduate Institute of Medical Education and Research, Nehru Hospital, Chandigarh 160012, IndiaInternal MedicineCardiologyHematologyHistopathologyGastroenterologyNeurosurgeryPharmacologyRadiodiagnosisPost Graduate Institute of Medical Education and Research, Chandigarh 160012, India.

PMID: 25600246 PMCID: PMC4321405 DOI: 10.1530/EC-14-0132

Abstract

The effectiveness and short-term safety of recombinant human GH (r-hGH) in acromegaly patients with GH deficiency (GHD) after treatment are not well established. The study includes ten subjects with acromegaly who had GHD treated with r-hGH for 6 months. Control groups consisted of ten age-, gender-, and BMI-matched healthy subjects and ten active acromegaly patients who were treatment naïve. Body composition, quality of life (QoL), muscle strength, lipid profile, and cardiovascular risk factors were assessed in all subjects at baseline, and the same parameters were reassessed after 6 months of therapy with r-hGH in acromegaly with GHD. Repeat magnetic resonance imaging of the sella was performed in treated subjects. Optical colonoscopy was done and biopsies were taken from multiple sites for proliferation indices (Ki67). The median duration of GHD was 17.8 months and dose of r-hGH administered was 5.7±1.5 μg/kg per day. There was improvement in bone mineral content (P=0.01), bone mineral density (P=0.04), muscle strength (P<0.001), total cholesterol (P=0.003), high-density cholesterol (P<0.001), and QoL - score (P=0.005), and reduction in low-density cholesterol (P=0.003) and triglyceride (P=0.004) after treatment. There was no change in lean body mass, total body fat, hsCRP, lipoprotein (a), and fibrinogen levels. There was a modest increase in plasminogen activator inhibitor 1 (P=0.002), but it was lower compared with healthy controls and treatment naïve acromegalics (P=0.007). Six month-r-hGH therapy improves body composition, atherogenic lipid profile, QoL, and muscle strength in GHD patients who had acromegaly. Long-term prospective studies are needed to evaluate the effect of r-hGH therapy in these patients.

© 2015 The authors.

Keywords: GH therapy; acromegaly; growth hormone deficiency

References

  1. Eur J Endocrinol. 2002 Jan;146(1):67-74 - PubMed
  2. Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17 - PubMed
  3. J Clin Endocrinol Metab. 2008 Jul;93(7):2531-8 - PubMed
  4. Clin Endocrinol (Oxf). 2005 Apr;62(4):473-9 - PubMed
  5. J Endocrinol Invest. 1997 Jun;20(6):305-11 - PubMed
  6. J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609 - PubMed
  7. Clin Endocrinol (Oxf). 1996 Apr;44(4):403-11 - PubMed
  8. Neuroendocrinology. 2006;83(3-4):211-7 - PubMed
  9. J Clin Endocrinol Metab. 2014 Jun;99(6):2018-29 - PubMed
  10. Pediatr Endocrinol Rev. 2004 Dec;2(2):209-15 - PubMed
  11. J Assoc Physicians India. 2010 Nov;58:670-3 - PubMed
  12. J Clin Endocrinol Metab. 2003 May;88(5):2113-8 - PubMed
  13. Genomics. 1988 Oct;3(3):230-6 - PubMed
  14. Eur J Endocrinol. 2008 Dec;159(6):705-12 - PubMed
  15. Am J Clin Nutr. 1992 May;55(5):918-23 - PubMed
  16. Arch Intern Med. 2011 Jun 27;171(12 ):1082-7 - PubMed
  17. Eur J Endocrinol. 2012 Jan;166(1):13-20 - PubMed
  18. J Clin Endocrinol Metab. 2000 Jul;85(7):2476-82 - PubMed
  19. Endocrine. 2008 Jun;33(3):270-6 - PubMed
  20. Pituitary. 2009;12(4):339-46 - PubMed
  21. J Clin Endocrinol Metab. 1995 Jan;80(1):153-9 - PubMed
  22. Clin Endocrinol (Oxf). 2004 May;60(5):630-6 - PubMed
  23. J Clin Endocrinol Metab. 2009 Jul;94(7):2471-7 - PubMed
  24. Thromb Haemost. 1996 Sep;76(3):422-8 - PubMed
  25. Eur J Endocrinol. 2009 Jul;161(1):37-42 - PubMed
  26. Coron Artery Dis. 1998;9(8):473-81 - PubMed
  27. Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):51-5 - PubMed
  28. Clin Endocrinol (Oxf). 2012 Sep;77(3):430-8 - PubMed
  29. Treat Endocrinol. 2004;3(5):309-18 - PubMed
  30. J Clin Endocrinol Metab. 2000 Nov;85(11):4104-12 - PubMed
  31. Ann Intern Med. 1996 Dec 1;125(11):883-90 - PubMed
  32. J Endocrinol. 2003 Dec;179(3):311-33 - PubMed
  33. Pituitary. 2012 Sep;15(3):386-92 - PubMed
  34. J Clin Endocrinol Metab. 2011 Jan;96(1):122-32 - PubMed
  35. J Clin Endocrinol Metab. 1992 Sep;75(3):833-7 - PubMed
  36. Front Endocrinol (Lausanne). 2013 Jun 04;4:64 - PubMed
  37. Eur J Endocrinol. 2014 Dec;171(6):717-26 - PubMed
  38. J Endocrinol. 2008 May;197(2):297-307 - PubMed
  39. J Clin Endocrinol Metab. 2003 Sep;88(9):4158-67 - PubMed
  40. N Engl J Med. 2006 Dec 14;355(24):2558-73 - PubMed
  41. J Clin Endocrinol Metab. 2010 Feb;95(2):567-77 - PubMed

Publication Types